SHG · Healthcare
Drug Manufacturers - Specialty & Generic
Changchun BCHT Biotechnology Co. A (688276) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $7.41B, P/E ratio is 18.00, net margin is -46.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Changchun BCHT Biotechnology Co. A (688276) has a reported market cap of $7.41B (data as of 2026-03-29).
The price-to-earnings (P/E) ratio for Changchun BCHT Biotechnology Co. A (688276) is 18.00 (data as of 2026-03-29).
Dividend yield is not available in the current snapshot for Changchun BCHT Biotechnology Co. A (688276). Check the MyAverix Finance app for the latest dividend data.
Changchun BCHT Biotechnology Co. A (688276) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
688276 is listed on SHG.
Changchun BCHT Biotechnology Co. A (688276) reports a net margin of -46.0% (data as of 2026-03-29).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.